



<!--?xml version='1.0' encoding='utf-8'?-->
		<rss version="2.0">
		   <channel>
		      <title>Biotechnology</title>
		      <link>http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437</link>
		      <description><![CDATA[Biotechnology is having an increasingly important impact on a number of sectors and disciplines. OECD has been working on biotechnology-related topics for over 25 years. These include scientific, industrial, health and agricultural applications. It also has a strong record on safety issues in biotechnology.]]></description>
		      <copyright>(c) OECD. All rights reserved</copyright>
			  <language>en</language>			  
		      <pubDate>Fri Jun 26 09:25:55 CEST 2009</pubDate>
		      <lastBuildDate>Fri Jun 26 09:25:55 CEST 2009</lastBuildDate>
		      <docs>http://www.oecd.org/RSS</docs>
		      <managingEditor>webmaster@oecd.org</managingEditor>
		      <webMaster>webmaster@oecd.org</webMaster>			  
			  
							      <item> 
							         <title><![CDATA[International Symposium on Opportunities and Challenges in the Emerging Field of Synthetic Biology]]></title>
							         <link><![CDATA[http://www.oecd.org/document/28/0,3343,en_2649_37437_43106012_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.  However, achieving the rewards offered by synthetic biology will require addressing a range of social, economic, ethical, and legal issues as well as overcoming scientific and technical challenges.  Given the enormous promise of synthetic biology, it is critical to develop a framework and to engage the public in an informed dialogue. For more information please contact:  Marie-Ange.Baucher@oecd.org]]></description>
							         <pubDate>Mon Jun 29 16:00:36 CEST 2009</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#43106134]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[OECD Workshop on Sustainability of Bio-based Products - Montreal, Canada ]]></title>
							         <link><![CDATA[http://www.oecd.org/document/8/0,3343,en_2649_37437_43177288_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[The workshop was held in Montreal, Canada on July 23-24, 2009. Some of the topics dicussed were:  existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels. Please, contact Mr Alexandre Bartsev at alexandre.bartsev@oecd.org for further details.]]></description>
							         <pubDate>Fri Aug 07 15:42:24 CEST 2009</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#43131167]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[OECD Biotechnology Statistics 2009]]></title>
							         <link><![CDATA[http://www.oecd.org/dataoecd/4/23/42833898.pdf]]></link>
							         <description><![CDATA[This new edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.]]></description>
							         <pubDate>Mon May 25 00:00:00 CEST 2009</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#42834120]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[Metrics to Support Informed Decision-making for Consumers of Biobased Products]]></title>
							         <link><![CDATA[http://www.oecd.org/dataoecd/37/48/42400999.pdf]]></link>
							         <description><![CDATA[The document focuses on efforts in the United States to develop metrics to support sound decision choices by industry and consumers in the selection and use of biobased products. Public policy initiatives have been important in spurring the movement toward increased use of biobased products in the effort to lighten the U.S. environmental footprint and enhance its energy security. This has included developing metrics based on sound science that also provide useful information to inform consumer selections of biobased products.]]></description>
							         <pubDate>Fri Mar 20 00:00:00 CET 2009</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#42402214]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[OECD Expert Workshop on Knowledge Markets in Life Sciences]]></title>
							         <link><![CDATA[http://www.oecd.org/document/55/0,3343,en_2649_37437_39407351_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[The Biotechnology Division of the OECD organized an experts workshop on “Knowledge Markets in the Life Sciences” in Washington, DC on October 16-17, 2008.  Its purpose was to explore whether Knowledge Markets could be more broadly used and to identify what governments may need to do to help make such new markets become a reality. This workshop is the first policy meeting to consider what new exchange mechanisms improve access to and use of the vast amounts of data, knowledge and information created in the biomedical sciences. ]]></description>
							         <pubDate>Wed Oct 22 00:00:00 CEST 2008</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#41541417]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[OECD Expert Workshop on Biomarkers and Targetted Therapies]]></title>
							         <link><![CDATA[http://www.oecd.org/document/48/0,3343,en_2649_37437_39405168_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[At a workshop organized by the OECD Biotechnology Division in October in the United Kingdom, experts discussed how to improve the development and use of biomarkers in health care.  Topics included:  data and knowledge sharing for biomarker research; the creation of an evidence base and the clinical evaluation of biomarkers; the regulatory and policy framework  for safe and efficient development of biomarkers; and business models for biomarker discovery, development and commercialization.]]></description>
							         <pubDate>Wed Oct 22 00:00:00 CEST 2008</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#41542060]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[Biotechnology, Innovation and Health]]></title>
							         <link><![CDATA[http://www.oecd.org/document/10/0,3343,en_2649_37437_33790794_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[The links between innovation, productivity, health and wealth are recognised by many countries and the need to encourage innovation is also apparent.  Investing in and  encouraging innovation is a priority for many jurisdictions as is the affordability, quality  and sustainability of healthcare systems.]]></description>
							         <pubDate>Fri Oct 24 00:00:00 CEST 2008</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#41564844]]></guid>
							      </item>							
							
							      <item> 
							         <title><![CDATA[Genetics and Genomics]]></title>
							         <link><![CDATA[http://www.oecd.org/document/20/0,3343,en_2649_37437_39405140_1_1_1_37437,00.html?rssChId=37437]]></link>
							         <description><![CDATA[The OECD Working Party on Biotechnology is developing Council Guidelines on human biobanks and genetic research databases (HBGRDs) through an expert group of member countries. The Guidelines are intended to assist both OECD and non-OECD governments in the development of policies applicable to HBGRDs and to provide guidance for private and public sector HBGRDs.]]></description>
							         <pubDate>Fri Oct 24 00:00:00 CEST 2008</pubDate>
							         <guid><![CDATA[http://www.oecd.org/topic/0,3373,en_2649_37437_1_1_1_1_37437,00.html?rssChId=37437#41564807]]></guid>
							      </item>							
							
		   </channel>
		</rss>
		